Результаты поиска

Surgical Intervention for Spinal Lesions Due to Multiple Myeloma: A Case Report.

Vertebral disease is a main source of morbidity (MM) in individuals with multiple myeloma. The effects of associated osteolytic lesions and vertebral fractures on severe pain, functional limits, spinal deformity, and cord compression are well recognized. Systemic therapy, radiation, cementoplasty (vertebroplasty/kyphoplasty), and radiofrequency ablation are now available therapeutic options for severe MM spinal pain. We here reported a case of a 45-year-old male who had complained of progressive symptoms of pathological spine fractures. He had been examined and investigated for the cause of ly

Совпадение в полном тексте источника
… The patient complained of headache and eye pain with no history of weight loss or a decrease in appetite. The patient came to the ER walking on his own without any walking aids. On examination, the patient was alert, conscious, ill-looking, and had a grossly intact neurological system. …

Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study.

BackgroundWearable sensors could be a simple way to quantify and characterize mobility in patients with hematologic cancer scheduled to receive autologous hematopoietic stem cell transplant (autoHSCT) and how they may be related to common treatment-related symptoms and side effects of induction chemotherapy.ObjectiveWe aimed to conduct a cross-sectional study comparing mobility in patients scheduled to receive autoHSCT with that in healthy, age-matched adult controls and determine the relationships between patient mobility and chemotherapy-related symptoms.MethodsPatients scheduled to receive

A Rare Case of Epidural Myeloma Presenting as Recurrent Subdural Bleeding.

Multiple myeloma (MM) is an incurable clonal B-cell malignancy that usually presents with neoplastic monoclonal plasma cells in either bone or soft tissues. Central nervous system involvement of the myeloma (CNS-MM), such as dural myeloma or intraparenchymal infiltration, or diffuse leptomeningeal involvement, is uncommon. Dural involvement of myeloma without parenchymal or leptomeningeal disease is even rarer, with only seven cases reported previously. We present a case of epidural myeloma in a 50-year-old man with known kappa light chain MM, presenting with multiple episodes of subdural hemo

Survival and ambulatory function after endoprosthetic replacement for metastatic bone tumor of the proximal femur.

The purpose of this study was to clarify the ambulatory functional and oncological outcomes of tumor excision and endoprosthetic reconstruction for a metastatic lesion of the proximal femur. Subjects comprised 40 patients (18 women, 22 men; average age 63.4 years). The mean follow-up periods were 15.2 months for patients dying of the disease, and 38.7 months for survivors. Seven patients were lost to follow-up for 1.9 to 13.1 months. Endoprosthesis was performed after intralesional aggressive curettage in 20 patients and following excision of the lesion with a clear margin, in another 20. Post

Roadmap for new practitioners to navigate the multiple myeloma landscape.

Multiple myeloma (MM) is a blood cancer in which monoclonal plasma cells cause end organ damage resulting in hypercalcemia, renal failure, anemia, and bone lesions. MM is considered incurable, however, recent advances in treatment have improved survival. Historically, MM has been treated with immunomodulatory drugs (IMiDs), proteosome inhibitors (PIs), and corticosteroids. While newer therapeutic approaches such as monoclonal antibodies and cellular therapies have broadened the treatment horizon, the selection and sequencing of these therapies has become more complex. This review aims to help

Усиление ремиэлизации в множестве склероза через M1 Muscarinic ацетилхолиновый рецептор.

Растет распространенность склероза (MS), однако по-прежнему требуется лечение, способное обратить вспять прогресс в развитии болезни. Одна из стратегий, которая продемонстрировала многообещающее изменение режима MS, заключается в воспрещении рецептора M1 — члена семейства мускаринических ацетилхолинов (mAChR). Считается, что антагонизм M1 mAChR является механизмом, с помощью которого Клемастин, развивающийся препарат, который был замечен в целях усиления миелинизации в исследованиях животных и клинических испытаниях этапа II, вызывает его эффект, стимулирующий миелинацию. Недавние исследования

Редкий случай конъюнктурного уринотракса и миэломатного плеурального эфлюмилия.

ВВЕДЕНИЕ: миэломатное плевральное эфилирование (МПЭ) представляет собой редкое осложнение множественной миеломы, происходящее в < 1% - случаи, связанные с плохим прогнозом. Еще одной редкой причиной плевральной эфлуции является утечка мочи в плевральную полость, как правило, из-за обструктивной урпатии или травмы. Несмотря на то, что оба условия в индивидуальном порядке являются редкими, об их параллельных случаях ранее не сообщалось. ПРЕДОСТАВЛЕНИЕ СЛУЧАИ: 81-year-old У человека с рецидивированной множественной миеломой были диспнея, гематурия и острая почечная недостаточность. Воображение вы

Solitary plasmacytoma in the maxillary sinus: 10-year follow-up.

Solitary plasmacytoma (SP) is an uncommon form of plasma cell neoplasm occurring intraosseously or in soft tissue and presents as a single mass of monoclonal plasma cells. SP in the maxillary sinus is rare and can be misdiagnosed as other maxillary sinus tumors. The essential examinations in patients with the initial diagnosis of plasmacytoma are bone marrow biopsy, serum and urine electrophoresis, and kappa/lambda ratio (κ:λ ratio) to rule out multiple myeloma (MM). Herein, a rare case of SP in the maxillary sinus treated by surgery and localized radiation is reported. At the 10-year follow-u

Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.

OBJECTIVE: Graft-versus-host disease (GVHD) is an immune-mediated multisystemic disorder and the leading cause of morbidity after allogeneic hematopoietic stem cell transplantation. Peripheral nervous system manifestations of GVHD are rare but often disabling. Whereas immune-mediated neuropathies are an established feature of GVHD, muscle cramps are not well characterized. METHODS: In a single-centre retrospective cohort we studied 27 patients (age 23 to 69 years) with GVHD (acute n = 6, chronic n = 21) who complained of symptoms suggestive of peripheral nervous system complications. Clinical

Необычайное представление множественной миеломы: плеуральная эфлуляция и эксклюзивное участие.

A 60-year-old Самка страдает от боли в животе, потери веса и усталости. Воображение выявило поджелудочную массу, двустороннюю плевральную эфлуцию, аскиты и литические костные повреждения. Расследования подтвердили наличие нескольких миэломы с лёгкой цепью ламбды. Сканирование позитроновых эмиссий (ПЕТ-СТ) показало обширную метаболически активную мягкую тканевую массу, охватывающую поджелудочную область, ретроперитонеум, медиастинум, паравертебральные области и множественные повреждения скелета с участием экстразональных мягких тканей, а также двустороннюю плевральную эфлуцию с метаболически ак

Two Случаи протеазонных ингибиторов связаны с тромботическими микроангиопатиями и анализом литературы.

Множественная миелома (ММ) является широко распространенной гематологической халатностью, при этом протеазонные ингибиторы (ИП) играют ключевую роль в ее терапевтическом регулировании. Несмотря на то, что ПИ, как правило, хорошо терпимы и связаны с относительно мягкими побочными эффектами, последние данные все чаще привлекают внимание к протеазной ингибиторной тромботической микроангиопатии (TMA, связанной с ИП). ПРЕДОСТАВЛЕНИЕ СЛЕДУЮЩЕГО ВОПРОСА: two :: случаи с высоким клиническим подозрением в связи с ТМА, связанной с ПИ, с уделением особого внимания диагностическому процессу и последующим

Hematology

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Dermatological manifestations of hematologic neoplasms. Part II: nonspecific skin lesions/paraneoplastic diseases.

Cutaneous manifestations occur in the course of hematologic malignancies and precede, accompany or occur late in relation to the diagnosis. They result from paraneoplastic phenomena, tumor infiltrations, immunosuppression resulting from the hematologic disease itself or its treatment. The dermatologist must be aware of these conditions that may be helpful both in the diagnosis of the underlying disease and in reducing patient morbidity. This review (part II) addresses the paraneoplastic dermatological changes associated with systemic hematologic malignancies.

A comprehensive update of extracutaneous involvement of mycosis fungoides: A narrative review of literature.

Mycosis fungoides, the most prevalent subtype of cutaneous T-cell lymphoma, primarily targets areas of the skin that of not exposed to sunlight. Nevertheless, it can involve extracutaneous tissues at any disease stage, especially during its advanced phases. Research suggests that all extracutaneous organs might be susceptible, though such cases are more commonly reported in autopsy studies and less so in clinical setting. The most recent comprehensive review of such extracutaneous manifestations in mycosis fungoides occurred almost a decade ago. With the aim of enhancing clinicians' understand

Female sex is associated with a lower risk of bone metastases and favourable prognosis in non-sex-specific cancers.

BackgroundThe objectives were to investigate the disparity in the prevalence of bone metastases (BM) between the sexes and to assess the effect of female sex on the development and prognosis of BM.MethodsCases of invasive non-sex-specific cancers diagnosed between 2010 and 2015 in the Surveillance, Epidemiology, and End Results (SEER) program were used. The prevalence of BM was calculated by combining the prevalence of BM among different cancers. Multivariable logistic regression and proportion hazard regression were conducted to investigate the effect of female sex, and the results were poole

Cutaneous presentation of Double Hit Lymphoma: A Case Report With Review of the Literature.

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL), representing approximately 25% of diagnosed NHL. DLBCL is heterogeneous disease both clinically and genetically. The 3 most common chromosomal translocations in DLBCL involve the oncogenes BCL2, BCL6, and MYC. Double hit (DH) DLBCL is an aggressive form in which MYC rearrangement is associated with either BCL2 or BCL6 rearrangement. Patients typically present with a rapidly growing mass, often with B symptoms. Extranodal disease is often present. Though there is a paucity of prospective trials in this

Antibodies to watch in 2026.

The Antibodies to Watch article series provides annual updates on commercial late-stage clinical development, regulatory review, and marketing approvals of antibody therapeutics. Since the first article was published in 2010, the late-stage pipeline has grown from 26 antibody therapeutics to over 200, while during the same time numerous molecules in late-stage studies either transitioned to regulatory review and were approved or were terminated. In this installment of the series, we recap first marketing approvals granted to 19 antibody therapeutics in 2025, discuss 26 molecules currently in r

Physical Characteristics Pertaining to Health-Related Quality of Life in Hospitalized Patients With Hematologic Malignancies: A Cross-Sectional Study.

Background Patients with hematologic malignancies often experience pre-existing physical decline, which is further exacerbated during chemotherapy, resulting in markedly reduced health-related quality of life (HRQOL). These functional impairments are largely attributable to modifiable factors such as physical inactivity and malnutrition. However, the precise relationships among body composition, physical function, and HRQOL in this population remain insufficiently understood. Therefore, this study aimed to identify key physical determinants of HRQOL in hospitalized patients with hematologic ma

Изучение воздействия программы ухода за больными на основе эффективности, интегрированной со стратегиями вмешательства в области питания, на результаты лечения нескольких больных миеломой с почечной неполноценностью.

ЦЕЛЬ: Изучение воздействия схемы ухода за больными на основе теории эффективности в сочетании с пищевым вмешательством на пациентов с множественной миеломой (ММ), связанной с почечной недостаточностью. МЕТОДЫ: Ninety-two Пациенты с MM были осложнены почечной недостаточностью в нашей больнице с апреля 2022 по апрель 2024 были произвольно разделены на контрольную группу (46 :: случаи с использованием традиционных медицинских сестер) и наблюдательной группы46 - случаи с использованием схемы ухода за больными, основанной на теории эффективности, в сочетании с мерами в области питания). Показатели

The 2024 Saudi Pharmacotherapy Didactic Curriculum Toolkit: A Modified Delphi Study.

BACKGROUND: Several pharmacy schools in Saudi Arabia (S.A.) refer to the American College of Clinical Pharmacy (ACCP) pharmacotherapy toolkit in developing their pharmacotherapy curriculum. However, the ACCP toolkit does not specifically address the healthcare needs of the Saudi population. A tailored pharmacotherapy curriculum that offers graduates the essential competencies to better serve the nation's needs is warranted. This study aims to develop a population-centered didactic pharmacotherapy toolkit for the Saudi population to assist pharmacy schools in designing pharmacotherapy course co